Try our Advanced Search for more refined results
Genetic Technologies Limited v. Bristol-Myers Squibb Company
Case Number:
1:12-cv-00394
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 30, 2014
BMS, Sanofi Get Gene Patent Partially Invalidated In IP Suit
A Delaware federal judge invalidated part of a DNA technology patent Genetic Technologies Ltd. accused Bristol-Myers Squibb Co. and a Sanofi-Aventis SA unit of infringing because it merely described a natural law, dooming the claim under the U.S. Supreme Court's landmark Mayo v. Prometheus decision.
-
February 04, 2014
BMS Says Genetic Technologies' DNA Tech Is Unpatentable
Bristol-Myers Squibb Co. on Tuesday urged a Delaware federal court to dismiss Australian company Genetic Technologies Ltd.'s suit accusing it of infringing patents relating to DNA technology, arguing the patents cover an unpatentable law of nature.